Key facts
- Simon Doyle appointed CEO of LUCENT Biopharma Ltd.
- The appointment is effective immediately.
- Dr. Matthew Goodman moves from CEO to Chief Medical Officer.
LUCENT Biophopharma Ltd. has announced a leadership transition. Simon Doyle, with prior experience at STEM, NeoHealthHub, and Cencora, will lead the company as CEO. Dr. Matthew Goodman, who founded LUCENT and served as its CEO, will now focus on the company's medical strategy as Chief Medical Officer.